Clinical trial
A Retrospective Observational Clinical Study on the Use of Continuous Glucose Monitoring for Glycemic Control in Adult and Pediatric Patients With Glycogen Storage Disease Type Ia (GSDIa)
NCT04708015 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Observational Clinical Study on the Use of Continuous Glucose Monitoring for Glycemic Control in Adult and Pediatric Patients With Glycogen Storage Disease Type Ia (GSDIa)
- Lead sponsor
- Ultragenyx Pharmaceutical Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 5, 2020
- Completion date
- March 4, 2022
- Enrollment
- 15 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
glycogen storage disease type ia